Niktimvo

Niktimvo is part of the Anti-CSF-1R Antibodies class and treats Chronic Graft Versus-Host Disease. Anti-CSF-1R antibodies, also known as anti-colony stimulating factor 1 receptor antibodies, are used to treat chronic graft versus host disease. They work by reducing the level of inflammatory cells in the body. Niktimvo is only available as a brand name drug.